Thor Medical ASA (LTS:0R6Y) Treasury Stock : kr0.00 Mil (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Thor Medical ASA Treasury Stock?

Treasury stock is the portion of shares that a company keeps in their own treasury. Thor Medical ASA's treasury stock for the quarter that ended in Dec. 2023 was kr0.00 Mil.

Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.

Thor Medical ASA Treasury Stock Historical Data

The historical data trend for Thor Medical ASA's Treasury Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Thor Medical ASA Treasury Stock Chart

Thor Medical ASA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Treasury Stock

Get a 7-Day Free Trial

Thor Medical ASA Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Dec22	Jun23	Dec23
Treasury Stock	Get a 7-Day Free Trial															-	-	-	-	-

Thor Medical ASA Treasury Stock Calculation

The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.

Thor Medical ASA (LTS:0R6Y) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Thor Medical ASA (LTS:0R6Y) » Definitions » Treasury Stock

Comparable Companies

Traded in Other Exchanges

TRMED:Norway 8NN:Germany

Address

Kjelsasveien 168 B, Oslo, NOR, 0884

Website

https://www.nordicnanovector.com

Nordic Nanovector ASA is a biopharmaceutical company. It is engaged in the development and commercialization of targeted therapeutics to improve the lives of patients with haematological cancers, such as non-Hodgkin lymphoma and leukaemia. The company's main clinical stage product is Betalutin.

Thor Medical ASA (LTS:0R6Y) Headlines

No Headlines